Vimarsana
Biggest News Aggregation in the World

Page 3 - Reported Net News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reported Net. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reported Net Today - Breaking & Trending Today

BioHarvest Sciences Inc.: BioHarvest Sciences Reports 2022 Sales Orders of USD 6.1M Representing 2.6X Increase over 2021 - Vimarsana News

BioHarvest Sciences Inc.: BioHarvest Sciences Reports 2022 Sales Orders of USD 6.1M Representing 2.6X Increase over 2021

Finished 2022 with Q4 sales orders of USD 2.7M representing a 3.3X increase over Q4 2021Sales orders growth for 2023 is projected to be 3X of 2022 and reach USD 17.3M - USD 20.3M Cash flow break even

Coty Delivers Strong 2Q23 Results Ahead of Expectations - Vimarsana News

Coty Delivers Strong 2Q23 Results Ahead of Expectations

NEW YORK--(BUSINESS WIRE)--Coty Inc. (NYSE: COTY) ("Coty" or "the Company") today announced its results for the second quarter of fiscal year 2023, ended December 31, 2022. The Company continued to

Coty Ends FY22 With Double-Digit Sales And Profit Growth Ahead of Guidance - Vimarsana News

Coty Ends FY22 With Double-Digit Sales And Profit Growth Ahead of Guidance

NEW YORK--(BUSINESS WIRE)--Coty Inc. (NYSE: COTY) ("Coty" or "the Company") today announced its results for the fourth quarter of fiscal year 2022, ended June 30, 2022. The Company delivered its

Emmaus Life Sciences Provides SEC Reporting Update - Vimarsana News

Emmaus Life Sciences Provides SEC Reporting Update

Similarly, any earnings releases and other press releases and investor communications containing information derived from such financial statements should no longer be relied upon.  Emmaus also provided an update on the filing of its delinquent quarterly reports.

Emmaus Life Sciences Provides SEC Reporting Update - Vimarsana News

Emmaus Life Sciences Provides SEC Reporting Update

/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease treatment, announced today that it has restated its financial...